Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Xiong, Mengshang
8  Ergebnisse:
Personensuche X
?
1

A Novel Blockade CD47 Antibody With Therapeutic Potential f..:

Lin, Fangzhen ; Xiong, Mengshang ; Hao, Wei...
Frontiers in Oncology.  10 (2021)  - p. , 2021
Link: https://doi.org/10.3389/..
 
?
2

Bispecific CD3-HAC carried by E1A-engineered mesenchymal st..:

Yang, Yuanyuan ; Zhang, Xiaolong ; Lin, Fangzhen...
Journal of Hematology & Oncology.  12 (2019)  1 - p. , 2019
Link: https://doi.org/10.1186/..
 
?
3

A Novel Blockade CD47 Antibody With Therapeutic Potential f..:

Lin, Fangzhen ; Xiong, Mengshang ; Hao, Wei...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813985/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
4

Video_1_A Novel Blockade CD47 Antibody With Therapeutic Pot..:

Fangzhen Lin ; Mengshang Xiong ; Wei Hao...
doi:10.3389/fonc.2020.615534.s002.  , 2021
Link: https://doi.org/10.3389/..
 
?
5

A Novel Blockade CD47 Antibody With Therapeutic Potential f..:

Fangzhen Lin ; Mengshang Xiong ; Wei Hao...
https://www.frontiersin.org/articles/10.3389/fonc.2020.615534/full.  , 2021
Link: https://doi.org/10.3389/..
 
?
6

Video_2_A Novel Blockade CD47 Antibody With Therapeutic Pot..:

Fangzhen Lin ; Mengshang Xiong ; Wei Hao...
doi:10.3389/fonc.2020.615534.s003.  , 2021
Link: https://doi.org/10.3389/..
 
?
7

Table_1_A Novel Blockade CD47 Antibody With Therapeutic Pot..:

Fangzhen Lin ; Mengshang Xiong ; Wei Hao...
doi:10.3389/fonc.2020.615534.s001.  , 2021
Link: https://doi.org/10.3389/..
 
?
8

Bispecific CD3-HAC carried by E1A-engineered mesenchymal st..:

Yuanyuan Yang ; Xiaolong Zhang ; Fangzhen Lin...
http://link.springer.com/article/10.1186/s13045-019-0723-8.  , 2019
Link: https://doi.org/10.1186/..
 
1-8